Caricamento...
Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
Omalizumab is an anti-IgE monoclonal antibody used in severe allergic asthma. Herein, we describe a case of eosinophilic granulomatosis with polyangiitis, which manifested 3 months after initiation of omalizumab therapy, while maintenance corticosteroid therapy dose was unchanged.
Salvato in:
| Pubblicato in: | BMJ Case Rep |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8323353/ https://ncbi.nlm.nih.gov/pubmed/34326107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-240078 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|